HOME >> MEDICINE >> NEWS
Immunex's TRAIL Molecule Shows Potential As Anti-Tumor Agent

SEATTLE, WA -- A preclinical study published in the journal Nature Medicine today demonstrated that TRAIL (TNF-related apoptosis-inducing ligand) suppresses tumor growth, and in some instances caused complete remission of tumors, by a direct and specific mechanism. The work described in the journal was conducted in mice by scientists at Immunex Corporation (NASDAQ:IMNX).

In the study, groups of mice were injected with tumor cells from a human breast cancer, or either of two different colon cancers. Following two weeks of daily injections with TRAIL, complete remission of all tumors was observed in a high proportion (70%-100%) of the treated mice. In contrast, the tumors of the untreated control mice grew progressively. Importantly, because of TRAIL's apparent specificity in targeting tumor cells, normal tissues showed no observable adverse effects.

"TRAIL is the first of a new generation of novel molecules that directly and selectively induce apoptosis of tumor cells and may have potential in the treatment of a wide variety of cancers," said David Lynch, Ph.D., senior staff scientist and senior author of the manuscript. "We are particularly excited by the apparent lack of toxicity shown in mouse studies with TRAIL to date."

Unlike most traditional chemotherapeutics, TRAIL is a naturally occurring immune system protein that is a member of the tumor necrosis factor (TNF) family. TRAIL binds to at least four distinct receptors found on many tumor cells and signals these cells to destroy themselves via a process known as apoptosis. Immunex scientists constructed a soluble form of TRAIL that was found to stimulate tumor cell destruction.

"We are very pleased about the results of the study and have promoted TRAIL to a high priority pre-development product," said Doug Williams, senior vice president, discovery research. "We will continue to study TRAIL as an anti-tumor agent in a variety of cancers."

In June of 1998, the U.S. Patent an
'"/>

Contact: Pam Rabe
prabe@immunex.com
206-470-4131
Immunex Corporation
2-Feb-1999


Page: 1 2

Related medicine news :

1. Gene therapy establishes a TRAIL to arthritis treatment
2. Molecule important in cell construction also critical in learning and memory
3. Molecule predicts colon cancer patient survival
4. Molecule pumped directly into brain improves Parkinsons disease symptoms
5. Molecule expressed early in pregnancy may help patients tolerate transplants
6. Molecules inhibit HIV protease, could lead to new line of attack against AIDS
7. UK Researchers Receive $1.14 Million NIH Grant To Study A Molecule That May Have A Role In Diseases Involving Oxidative Cell Death
8. Randomized Contolled Study Shows Neostigmine Is An Effective Treatment For Acute Colonic Pseudo-Obstruction
9. Research Shows That Noncompliance Is Responsible For Half The Cases Of Nonresponse To Antihypertensive Drug Treatment
10. Anal Cancer Screening For HIV-Positive Gay And Bisexual Men Would Save Lives And Be Cost Effective, New Study Shows
11. Anti-Depressant Drug Shows Promise As Weight-Loss Treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/2/2020)... ... June 02, 2020 , ... ... company that has been serving the healthcare industry for more than a decade, ... virtual and integrated care offerings. , In 2010, RemetricHealth, then known as PMD ...
(Date:5/30/2020)... ... May 30, 2020 , ... HashCash Consultants is ... can meet the needs of a COVID-riddled world, while shaping a robust healthcare ... by the necessary compliances and augment the caregiving standards through the establishment of ...
(Date:5/27/2020)... ... ... The podiatrists and foot doctors of Advanced Foot & Ankle Specialists are ... Arbor Michigan. Dr. Tomasz Biernacki states that “Podiatrists can help support the ... We have been seeing patients in the hospital for the past 3 months, but ...
(Date:5/26/2020)... ... ... Today TRC Companies (“ TRC ”) announced the release of its ... and leaders assess whether their organizations are prepared to move forward as the country ... to assist business leaders evaluate their readiness relative to CDC guidance and provides ideas ...
(Date:5/21/2020)... ... May 21, 2020 , ... In response to the Coronavirus pandemic, Industrial Magnetics, ... to open swing-style doors without using their hands or fingertips. , The ... open using their forearm, wrist or elbow when entering or exiting a room. , ...
Breaking Medicine News(10 mins):
(Date:6/5/2020)... ... June 04, 2020 , ... Worldwide Business with kathy ireland® ... on Sunday, June 7, 2020 and Wednesday, June 10, 2020 at 8:00pm ET / ... , As leaders in their industries, the companies featured demonstrate the unique branding opportunity ...
(Date:6/5/2020)... ... 05, 2020 , ... In honor of Pride Month, a month dedicated to ... to spread awareness about the multiple family building options available to the LGBTQ ... Manhattan office , will host an LGBTQ Family Building webinar on Thursday, June 18, ...
(Date:6/4/2020)... (PRWEB) , ... June 04, 2020 , ... One minute ... restricted, and “social distancing” entered the lexicon. COVID-19 turned the world on its head, ... “sheltered in place.” , The AutismOne annual conference went from a physical event to ...
Breaking Medicine Technology:
Cached News: